Trifluridine/Tipiracil Hcl

Brand name: Lonsurf

Rank #361 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$27.3M

Total Cost

Share:

2,430

Total Claims

$27.3M

Total Cost

145

Prescribers

$11K

Cost per Claim

0

Beneficiaries

2,432

30-Day Fills

$188K

Avg Cost/Provider

17

Avg Claims/Provider

Share of Medicare Part D Spending

0.01%

of total Medicare Part D spending

$27.3M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $27.3M total

🔎 Data Overview

💰

At $11,240 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

🔍

Average cost of $188,362 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Trifluridine/Tipiracil Hcl

#ProviderSpecialtyLocationClaimsCost
1Oscar SignoriMedical OncologyDearborn, MI34$639K
2Bilal AnsariMedical OncologyMishawaka, IN38$558K
3Naveed ChowhanMedical OncologySeymour, IN21$485K
4Peter JiangHematology-OncologyColumbus, GA24$395K
5Thomas AbramsMedical OncologyBoston, MA23$373K
6Delia RadovichHematology-OncologyNewnan, GA37$360K
7Kota ShekarHematology-OncologyTempleton, CA33$351K
8Olatunji AleseHematology-OncologyAtlanta, GA30$344K
9Gregory GilmoreHematology-OncologyCorona, CA30$343K
10Scott FleischauerMedical OncologyArlington, TX24$343K
11Azriel HirschfeldHematology-OncologyBrooklyn, NY14$337K
12Antoine ChahineMedical OncologyCanfield, OH18$335K
13Shawn TaiHematology-OncologyAthens, TX33$334K
14Bradley CliffordHematology-OncologyAkron, OH34$315K
15Balagopal KeralavarmaHematology-OncologyMerrillville, IN30$312K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
358Colchicine (Colchicine)$27.5M314,046
359Valsartan/Hydrochlorothiazide (Valsartan-Hydrochlorothiazide)$27.5M510,583
360Ropinirole Hcl (Ropinirole Hcl)$27.5M1,204,903
361Trifluridine/Tipiracil Hcl (Lonsurf)$27.3M2,430
362Memantine Hcl/Donepezil Hcl (Namzaric)$27.2M46,134
363Solifenacin Succinate (Solifenacin Succinate)$27.1M343,174
364Insulin Aspart (Niacinamide) (Fiasp Flextouch)$27.0M24,598

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology